Diabetes Research and Clinical Practice 1991: Vol 12 Index

9 Pages·1991·1.8 MB·English

Diabetes Research and Clinical Practice, 12 (1991) 219-000
© 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50
Author Index to Volume 12 (1991)
Adamson, U., see Liu, D., 19 Delaunay, C., see Costagliola, D., 209
Akabane, S., see Ide, M., 157 Demeulemeester, R., see Costagliola, D., 209
Albeanu, A., see Liniger, C., 25 Diepersloot, R.J.A., see Bouter, K.P., 61
Alberti, K.G.M.M., see Marsiaj, H.I., 129 Donnet, J.P., see Costagliola, D., 209
Antony, G., Cooper, S.G. and Svejkar, L.C., Continuous
subcutaneous insulin infusion (CSII) and insulin anti- Eastman, S., Markholst, H., Wilson, D. and Lernmark, A.,
bodies in rabbits, 41 Leukocytosis at the onset of diabetes in crosses of inbred
Aoki, M., see Matsutani, A., 35 BB rats, 113
Aoki, S., see Hasegawa, G., 143 Erkelens, D.W., see Bouter, K.P., 61
Arauz, C., see Ramirez, L., 85 Eschwege, E., see Costagliola, D., 209
Assal, J.Ph., see Liniger, C., 25
Atputharajah, Y., see Koh, K.T.C., 11 Figliomeni, B., see Bianchi, R., 107
Fiori, M.G., see Bianchi, R., 107
Bechgaard, E., see Gizurarson, S., 71 Fong, N.P., see Koh, K.T.C., 11
Bhatia, S. and Sharma, K.N., Taste impairment for glucose Freeman, S.L., O’Brien, P.C. and Rizza, R.A., Use of human
in diabetic PTC tasters and non-tasters, 193 ultralente as the basal insulin component in treatment of
Bianchi, R., Triban, C., Marini, P., Figliomeni, B., Paro, M., patients with IDDM, 187
Italiano, G., Prosdocimi, M. and Fiori, M.G., Inner ester
derivatives of gangliosides protect autonomic nerves of Gizurarson, S. and Bechgaard, E., Intranasal administration
alloxan-diabetic rats against Na*, K *-ATPase activity of insulin to humans, 71
defects, 107 Goh, L.G., see Koh, K.T.C., 11
Bloise, D., see Liniger, C., 25 Gupta, D.K., Verma, L.K., Khosla, P.K. and Dash, S.C., The
Bouter, K.P., Diepersloot, R.J.A., Van Romunde, L.K.J., prevalence of microalbuminuria in diabetes: a study from
Uitslager, R., Masurel, N., Hoekstra, J.B.L. and Erkelens, North India, 125
D.W., Effect of epidemic influenza on ketoacidosis,
pneumonia ad death in diabetes mellitus: a hospital Hasegawa, G., Tsutsumi, Y., Aoki, S., Sawada, M..,
register survey of 1976-1979 in The Netherlands, 61 Setoguchi, J., Nakamura, N., Nakano, K., Kondo, M. and
Kanatsuna, T., Relationship between erythrocyte sorbitol
Catalano, C., see Marsiaj, H.I., 129 content and diabetic microangiopathy in patients with
Cha, T., Tahara, Y., Yamato, E., Yoneda, H., Ikegami, H., non-insulin-dependent diabetes mellitus: the study of a
Noma, Y., Shima, K. and Ogihara, T., Renal handling of diet loading test, 143
glycated albumin in non-insulin-dependent diabetes Hellenbrand, D., see Ramirez, L., 85
mellitus with nephropathy, 149 Hirano, T., Mamo, J.C.L., Takeuchi, H., Nagano, S. and
Chan, Y.C., see Koh, K.T.C., 11 Takahashi, T., Correlation of insulin deficiency and
Cooper, S.G., see Antony, G., 41 hypertriglyceridemia in diabetic rats, 173
Costagliola, D., Delaunay, C., Moutet, J.P., Kankambega, P., Hisatomi, A., see Takatsuki, H., 137
Demeulemeester, R., Donnet, J.P., Papoz, L. and Hoekstra, J.B.L., see Bouter, K.P., 61
Eschwege, E., The prevalence of diabetes mellitus in the Home, P.D., see Marsiaj, H.I., 129
adult population of Guadeloupe as estimated by history
or fasting hyperglycemia, 209 Ide, M., Katayama, S., Akabane, S., Inaba, M., Maruno, Y.,
Negishi, K., Suzuki, M., Takahashi, K., Itabashi, A. and
Dash, S.C., see Gupta, D.K., 125 Ishii, J., Effect of Alphal-blockade on diminished forearm
De Leeuw, I., see Van Gaal, L., 99 blood flow in diabetics, 157
220
Ikegami, H., see Cha, T., 149 non-insulin-dependent (type 2) diabetes mellitus: a retro-
Inaba, M., see Ide, M., 157 spective audit, 129
Ishii, H., see Takatsuki, H., 137 Maruno, Y., see Ide, M., 157
Ishii, J., see Ide, M., 157 Masurel, N., see Bouter, K.P., 61
Itabashi, A., see Ide, M., 157 Matsuda, M., see Matsutani, A., 35
Italiano, G., see Bianchi, R., 107 Matsutani, A., Kaku, K., Aoki, M., Mori, K., Matsuda, M.
and Kaneko, T., Possible mechanism of proteolysis for
Kaku, K., see Matsutani, A., 35 the extrapancreatic action of tolbutamide, 35
Kanatsuna, T., see Hasegawa, G., 143 Meenakshi, S., see Koh, K.T.C., 11
Kaneko, T., see Matsutani, A., 35 Miltényi, M., see Szabo, A., 91
Kankambega, P., see Costagliola, D., 209 Moberg, E., see Liu, D., 19
Katayama, S., see Ide, M., 157 Moody, J.F., see Liniger, C., 25
Kawai, K., Suzuki, S., Murayama, Y., Watanabe, Y. and Mori, K., see Matsutani, A., 35
Yamashita, K., Comparison of -cell function after long- Moutet, J.P., see Costagliola, D., 209
term treatment with either insulin, insulin plus gliclazide Murayama, Y., see Kawai, K., 163
or gliclazide in neonatal streptozotocin-induced non-
insulin-dependent diabetic rats, 163 Nagano, S., see Hirano, T., 173
Kenesei, E, see Szabd, A., 91 Nagase, S., see Takatsuki, H., 137
Khosla, P.K., see Gupta, D.K., 125 Nagy, I., see Szabo, A., 91
Koh, K.T.C., Goh, L.G., Lam, S.L., Fong, N.P., Quah, Q.K., Nakamura, N., see Hasegawa, G., 143
Meenakshi, S., Chan, Y.C. and Atputharajah, Y., Knowl- Nakano, K., see Hasegawa, G., 143
edge and concerns of newly diagnosed NIDDM patients Nakashima, N., see Takatsuki, H., 137
in Singapore, 11 Nawata, H., see Takatsuki, H., 137
Kondo, M., see Hasegawa, G., 143 Negishi, K., see Ide, M., 157
Krans, H.M.J., see Nijs, H.G.T., 1 Nijs, H.G.T., Radder, J.K., Poorthuis, B.J.H.M. and Krans,
Kung, A.W.C., see Lam, K.S.L., 181 H.M.J., Glucose disposal and intermediary metabolism
Korner, A., see Szabo, A., 91 during one year of continuous subcutaneous insulin infu-
sion (CSII), 1
Lam, K.S.L., Li, D.F., Lauder, I.J., Lee, C.P., Kung, A.W.C. Nishikawa, M., see Sato, Y., 53
and Ma, J.T.C., Prediction of persistent carbohydrate Noma, Y., see Cha, T., 149
intolerance in patients with gestational diabetes, 181
Lam, S.L., see Koh, K.T.C., 11 O’Brien, P.C., see Freeman, S.L., 187
Lauder, I.J., see Lam, K.S.L., 181 Ogihara, T., see Cha, T., 149
Lee, C.P., see Lam, K.S.L., 181
Lernmark, A., see Eastman, S., 113 Papoz, L., see Costagliola, D., 209
Li, D.F., see Lam, K.S.L., 181 Paro, M., see Bianchi, R., 107
Lim, T.O., Prevalence, age at diagnosis, clinical characteris- Poorthuis, B.J.H.M., see Nijs, H.G.T., 1
tics and treatment of diabetes in the young in Pahang, Prodocimi, M., see Bianchi, R., 107
Malaysia, 201
Liniger, C., Albeanu, A., Moody, J.F., Richez, J., Bloise, D. Quah, Q.K., see Koh, K.T.C., 11
and Assal, J.Ph., The Thermocross: a simple tool for
rapid assessment of thermal sensation thresholds, 25 Radder, J.K., see Nijs, H.G.T., 1
Lins, P.-E., see Liu, D., 19 Ramirez, L., Rosenstock, J., Arauz, C., Hellenbrand, D. and
Liu, D., Moberg, E., Wredling, R., Lins, P.-E. and Adamson, Raskin, P., Low prevalence of microalbuminuria in
U., Insulin absorption is faster when keeping the infusion normotensive patients with insulin-dependent diabetes
site in use for three days during continuous subcutaneous mellitus, 85
insulin infusion, 19 Raskin, P., see Ramirez, L., 85
Richez, J., see Liniger, C., 25
Ma, J.T.C., see Lam, K.S.L., 181 Rizza, R.A., see Freeman, S.L., 187
Mamo, J.C.L., see Hirano, T., 173 Rosenstock, J., see Ramirez, L., 85
Marini, P., see Bianchi, R., 107
Markholst, H., see Eastman, S., 113 Sato, Y., Nishikawa, M., Shinkai, H. and Sukegawa, E.,
Marsiaj, H.I., Catalano, C., Sum, C.F., Home, P.D. and Possibility of ideal blood glucose control by a new oral
Alberti, K.G.M.M., Management of newly diagnosed hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-
carbonyl]-D-phenylalanine (A-4166), and its stimulatory Takeuchi, H., see Hirano, T., 173
effect on insulin secretion in animals, 53 Triban, C., see Bianchi, R., 107
Sawada, M., see Hasegawa, G., 143 Tsutsumi, Y., see Hasegawa, G., 143
Setoguchi, J., see Hasegawa, G., 143
Sharma, K.N., see Bhatia, S., 193 Uitslager, R., see Bouter, K.P., 61
Shima, K., see Cha, T., 149 Umeda, F., see Takatsuki, H., 137
Shinkai, H., see Sato, Y., 53
Sukegawa, E., see Sato, Y., 53 Van Acker, K., see Van Gaal, L., 99
Sum, C.F., see Marsiaj, H.I., 129 Van Gaal, L., Vansant, G., Van Acker, K. and De Leeuw, L.,
Suzuki, M., see Ide, M., 157 Decreased hepatic insulin extraction in upper body
Suzuki, S., see Kawai, K., 163 obesity: relationship to unbound androgens and sex hor-
Svejkar, L.C., see Antony, G., 41 mone binding globulin, 99
Szabo, A., Kenesei, E., Kdrner, A., Miltényi, M., Scziics, L. Van Romunde, L.K.J., see Bouter, K.P., 61
and Nagy, I., Changes in plasma and urinary amino acid Vansant, G., see Van Gaal, L., 99
levels during diabetic ketoacidosis in children, 91 Verma, L.K., see Gupta, D.K., 125
Sztics, L., see Szabo, A., 91
Watanabe, Y., see Kawai, K., 163
Tahara, Y., see Cha, T., 149 Wilson, D., see Eastman, S., 113
Takahashi, K., see Ide, M., 157 Wredling, R., see Liu, D., 19
Takahashi, T., see Hirano, T., 173
Takatsuki, H., Ishii, H., Yamauchi, T., Nakashima, N., Yamashita, K., see Kawai, K., 163
Nagase, S., Hisatomi, A., Umeda, F. and Nawata, H., A Yamato, E., see Cha, T., 149
case of insulin allergy: the crystalline human insulin may Yamauchi, T., see Takatsuki, H., 137
mask its antigenicity, 137 Yoneda, H., see Cha, T., 149

Diabetes Research and Clinical Practice, 12 (1991) 223-226
© 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50
Key Word Index to Volume 12 (1991)
A-1466 Crystalline human insulin
— Sulfonylureas; Glycemic control; Insulin; Glucagon, 53 — Insulin allergy, 137
Absorption promoter
— Insulin; Intranasal administration, 71 Diabetes
Acidosis — Influenza;Pneumonia; Acidosis; Excess mortality, 61
— Influenza; Diabetes; Pneumonia; Excess mortality, 61 Diabetes
Albuminuria — Triglyceride kinetics; Hypertriglyceridemia; Insulin;
—Glycated albumin; Enzyme-immunoassay; Diabetic Rat, 173
nephropathy; Charge selectivity, 149 Diabetes in the young
Alloxan-induced diabetic neuropathy — Malaysia; Epidemiology; Prevalence of insulin-depend-
— Ganglioside inner ester derivative; Rat vagus nerve; ent-diabetes mellitus; Non-insulin-dependent diabetes of
Na*t, K*-ATPase, 107 the young, 201
Anthropometry Diabetes mellitus
— Upper body obesity; Hyperinsulinism; Hepatic insulin — Microalbuminuria; Retinopathy, 125
extraction; Sex hormone, 100 Diabetes mellitus
Audit — Forearm blood flow; Essential hypertension, 157
— Non-insulin-dependent diabetes mellitus; Obesity; Diabetes mellitus
Hypertension; Lipid; Glycaemic control, 129 — Gustatory; Taster; Non-taster; Palatability, 193
Autoimmunity Diabetes mellitus
— Insulin-dependent diabetes; Eosinophilia; — Epidemiology; Caribbean area; Prevalence; Obesity;
Neutrophilia; Insulitis, 113 Ethnic group; Family history, 209
Diabetic ketoacidosis
Basal insulin — Plasma amino acid; Urinary amino acid; Tubular dys-
— Human ultralente; Intensive insulin therapy; Insulin function, 91
absorption, 187 Diabetic microangiopathy
— Erythrocyte sorbitol content; Polyol pathway; Diet
Caribbean area loading test, 143
— Diabeters mellitus; Epidemiology; Prevalence; Obesity; Diabetic nephropathy
Ethnic group; Family history, 209 — Albuminuria; Glycated albumin; Enzyme-immuno-
Charge selectivity assay; Charge selectivity, 149
— Albuminuria; Glycated albumin; Enzyme-immuno- Diet loading test
assay; Diabetic nephropathy, 149 — Erythrocyte sorbitol content; Polyol pathway; Diabetic
Compliance microangiopathy, 143
— Patient knowledge; NIDDM; Educational level; Con-
cerns, 11 Educational level
Concerns — Patient knowledge; NIDDM; Compliance; Concerns,
— Patient knowledge; NIDDM; Compliance; Educational 11
level, 11 Enzyme-immunoassay
Continuous subcutaneous insulin infusion — Albuminuria; Glycated albumin; Diabetic nephro-
— Metabolite profile; Type 1 diabetes; Insulin resistance, pathy; Charge selectivity, 149
2 Eosinophilia
Continuous subcutaneous insulin infusion — Insulin-dependent diabetes; Neutrophilia; Autoimmu-
— Rabbit; Insulin antibodies; Insulins; Plastics, 41 nity; Insulitis, 113
224
Epidemiology Hyperinsulinism
— Diabetes in the young; Malaysia; Prevalence of insulin- — Upper body obesity; Hepatic insulin extraction; Sex
dependent-diabetes mellitus; Non-insulin-dependent hormone; Anthropometry, 100
diabetes of the young, 201 Hypertension
Epidemiology —Non-insulin-dependent diabetes mellitus; Obesity;
— Diabetes mellitus; Caribbean area; Prevalence; Obesi- Lipid; Glycaemic control; Audit, 129
ty; Ethnic group; Family history, 209 Hypertriglyceridemia
Erythrocyte sorbitol content — Triglyceride kinetics; Insulin; Diabetes; Rat, 173
-Polyol pathway; Diet loading test; Diabetic
microangiopathy, 143 Influenza
Essential hypertension — Diabetes; Pneumonia; Acidosis; Excess mortality, 61
— Forearm blood flow; Diabetes mellitus, 157 Insulin
Ethnic group — A-1466; Sulfonylureas; Glycemic control; Glucagon, 53
— Diabetes mellitus; Epidemiolgy; Caribbean area; Pre- Insulin
valence; Obesity; Family history, 209 — Intranasal administration; Absorption promoter, 71
Excess mortality Insulin
— Influenza; Diabetes; Pneumonia; Acidosis, 61 — Triglyceride kinetics; Hypertriglyceridemia; Diabetes;
Extrapancreatic action Rat, 173
— Proteolysis; Tolbutaminde; F-2,6-P2, 35 Insulin absorption
— Type1 (insulin-dependent) diabetes mellitus; Insulin
F-2,6-P2 pump; Insulin infusion system; Pharmacokinetics, 19
— Proteolysis; Tolbutamide; Extrapancreatic action, 35 Insulin absorption
Family history — Human ultralente; Basal insulin; Intensive insulin ther-
— Diabetes mellitus; Epidemiology; Caribbean area; Pre- apy, 187
valence; Obesity; Ethnic group, 209 Insulin allergy
Foot ulceration — Crystalline human insulin, 137
— Thermal sensation; Neuropathy; Prevention, 25 Insulin antibodies
Forearm blood flow —Continuous subcutaneous insulin infusion; Rabbit;
— Diabetes mellitus; Essential hypertension, 157 Insulins; Plastics, 41
Insulin infusion system
Ganglioside inner ester derivative — Type 1 (insulin-dependent) diabetes mellitus; Insulin
— Alloxan-induced diabetic neuropathy; Rat vagus nerve; pump; Pharmacokinetics; Insulin absorption, 19
Na*,K*-ATPase, 107 Insulin pump
Gestational diabetes mellitus — Type 1 (insulin-dependent) diabetes mellitus; Insulin
— Oral glucose tolerance test; Postpartum flucose toler- infusion system; Pharmacokinetics; Insulin absorption,
ance; Prediction; Logistic discrimination, 181 19
Glucagon Insulin resistance
— A-1466; Sulfonylureas; Glycemic control; Insulin, 53 —Continuos subcutaneous insulin infusion; Metabolite
Glycaemic control profile; Type 1 diabetes, 2
— Non-insulin-dependent diabetes mellitus; Obesity; Insulin secretion
Hypertension; Lipid; Audit, 129 — Insulin treatment; Sulfonylurea; Non-insulin-depend-
Glycated albumin ent diabetes mellitus, 163
— Albuminuria; Enzyme-immunoassay; Diabetic nephro- Insulin treatment
pathy; Charge selectivity, 149 — Sulfonylurea; Insulin secretion; Non-insulin-dependent
Glycemic control diabetes mellitus, 163
— A-1466; Sulfonylureas; Insulin; Glucagon, 53 Insulin-dependent diabetes
Gustatory — Eosinophilia; Neutrophilia; Autoimmunity; Insulitis,
— Diabetes mellitus; Taster; Non-taster; Palatability, 193 113
Insulins
Hepatic insulin extraction — Continuous subcutaneous insulin infusion; Rabbit;
— Upper body obesity; Hyperinsulinism; Sex hormone; Insulin antibodies; Plastics, 41
Anthropometry, 100 Insulitis
Human ultralente — Insulin-dependent diabetes; Eosinophilia;
— Basal insulin; Intensive insulin therapy; Insulin absorp- Neutrophilia; Autoimmunity, 113
tion, 187
225
Intensive insulin therapy Palatability
-— Human ultralente; Basal insulin; Insulin absorption, — Diabetes mellitus; Gustatory; Taster; Non-taster, 193
187 Patient knowledge
Intranasal administration -— NIDDM; Compliance; Educational level; Concerns, | 1
— Insulin; Absorption promoter, 71 Pharmacokinetics
-— Type 1 (insulin-dependent) diabetes mellitus; Insulin
Lipid pump; Insulin infusion system; Insulin absorption, 19
—Non-insulin-dependent diabetes mellitus; Obesity; Plasma amino acid
Hypertension; Glycaemic control; Audit, 129 - Urinary amino acid; Diabetic ketoacidosis; Tubular
Logistic discrimination dysfunction, 91
— Gestational diabetes mellitus; Oral glucose tolerance Plastics
test; Postpartum glucose tolerance; Prediction, 181 — Continuous subcutaneous insulin infusion; Rabbit;
Insulin antibodies; Insulins, 41
Malaysia Pneumonia
— Diabetes in the young; Epidemiology; Prevalence of — Influenza; Diabetes; Acidosis; Excess mortality, 61
insulin-dependent-diabetes mellitus; Non-insulin-de- Polyol pathway
pendent diabetes of the young, 201 -—Erythrocyte sorbitol content; Diet loading test;
Metabolite profile Diabetic microangiopathy, 143
— Continuous subcutaneous insulin infusion; Type 1 Postpartum glucose tolerance
diabetes; Insulin resistance, 2 — Gestational diabetes mellitus; Oral glucose tolerance
Microalbuminuria test; Prediction; Logistic discrimination, 181
— Diabetes mellitus; Retinopathy, 125 Prediction
— Gestational diabetes mellitus; Oral glucose tolerance
NIDDM test; Postpartum glucose tolerance; Logistic discrimi-
— Patient knowledge; Compliance; Educational level; nation, 181
Concerns, 11 Prevalence of insulin-dependent-diabetes mellitus
Na*, K*-ATPase — Diabetes in the young; Malaysia; Epidemiology; Non-
— Ganglioside inner ester derivative; Alloxan-induced insulin-dependent diabetes of the young, 201
diabetic neuropathy; Rat vagus nerve, 107 Prevalence
Neuropathy — Diabetes mellitus; Epidemiology; Caribean area; Obe-
— Thermal sensation; Foot ulceration; Prevention, 25 sity; Ethnic group; Family history, 209
Neutrophilia Prevention
— Insulin-dependent diabetes; Eosinophilia; Autoimmu- — Thermal sensation; Neuropathy; Foot ulceration, 25
nity; Insulitis, 113 Proteolysis
Non-insulin-dependent diabetes mellitus — Tolbutamide; F-2,6-P2; Extrapancreatic action, 35
— Obesity; Hypertension; Lipid; Glycaemic control;
Audit, 129 Rabbit
Non-insulin-dependent diabetes mellitus — Continuous subcutaneous insulin infusion; Insulin anti-
— Insulin treatment; Sulfonylurea; Insulin secretion, 163 bodies; Insulins; Plastics, 41
Non-insulin-dependent diabetes of the young Rat
— Diabetes in the young; Malaysia; Epidemiology; Preva- -— Triglyceride knetics; Hypertriglyceridemia; Insulin;
lence of insulin-dependent-diabetes mellitus, 201 Diabetes, 173
Non-taster Rat vagus nerve
— Diabetes mellitus; Gustatory; Taster; Palatability, 193 — Ganglioside inner ester derivative; Alloxan-induced
diabetic neuropathy; Na*, K*-ATPase, 107
Obesity Retinopathy
— Non-insulin-dependent diabetes mellitus; Hyperten- — Diabetes mellitus; Microalbuminuria, 125
sion; Lipid; Glycaemic control; Audit, 129
Obesity Sex hormone
— Diabetes mellitus; Epidemiology; Carribbean area; — Upper body obesity; Hyperinsulinism; Hepatic insulin
Prevalence; Ethnic group; Family history, 209 extraction; Anthropometry, 100
Oral glucose tolerance test Sulfonylureas
— Gestational diabetes mellitus; Postpartum glucose — A-1466; Glycemic control; Insulin; Glucagon, 53
tolerance; Prediction; Logistic discrimination, 181 Sulfonylurea
—Insulin treatment; Insulin secretion; Non-insulin-
dependent diabetes mellitus, 163
226
Taster Type | (insulin-dependent) diabetes mellitus
— Diabetes mellitus; Gustatory; Non-taster; Palatability, -—Insulin pump; Insulin infusion system; Pharmaco-
193 kinetics; Insulin absorption, 19
Thermal sensation Type 1 diabetes
— Neuropathy; Foot ulceration; Prevention, 25 — Continuous subcutaneous insulin infusion; Metabolite
Tolbutamide profile; Insulin resistance, 2
— Proteolysis; F-2,6-P2; Extrapancreatic action, 35
Triglyceride kinetics Upper body obesity
— Hypertriglyceridemia; Insulin; Diabetes; Rat, 173 — Hyperinsulinism; Hepatic insulin extraction; Sex hor-
Tubular dysfunction mone; Anthropometry, 100
-— Plasma amino acid; Urinary amino acid; Ciabetic Urinary amino acid
ketoacidosis, 91 — Plasma amino acid; Diabetic ketoacidosis; Tubular
dysfunction, 91